ProMIS Neurosciences Inc. (PMN)
NASDAQ: PMNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 10:14 AM ET
PMN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $83.19M
- EPS (TTM)
- -$11.65
- Dividend yield
- None
- 52-week range
- 6.27 – 27.40
- Day range
- 8.78 – 9.37
- Volume / Avg
- 8.53K / 84.01K
- Beta
- —
- Shares outstanding
- 8.97M
- Next earnings
- Nov 13, 2026
52-week range
PMN stock today
ProMIS Neurosciences (PMN) is trading at $9.28 on Oct 8, up 1.72% (+$0.1567), versus the S&P 500's 0.24% decline. Shares are 66.1% below their 52-week high of $27.40, set on Mar 5, 2026 and 48.0% above the 52-week low of $6.27, near the bottom of the past year's range. PMN is up 33.5% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 32.4%.
ProMIS Neurosciences has posted a net loss over the last twelve months (EPS of -$11.65), so its P/E ratio is not meaningful. ProMIS Neurosciences's next earnings report is expected on Nov 13, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About ProMIS Neurosciences
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Earnings
Earnings history- Next report
- Nov 13, 2026
ProMIS Neurosciences peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TELOTelomir Pharmaceuticals Inc. | 1.10 | -1.44% | $81.26M | vs PMN |
| EQEquillium Inc. | 1.35 | -2.88% | $85.60M | vs PMN |
| CTORCitius Oncology Inc. | 0.821 | -4.09% | $86.83M | vs PMN |
| ACRVAcrivon Therapeutics Inc. | 1.81 | -3.99% | $77.35M | vs PMN |
| OKUROnKure Therapeutics Inc. Class A | 2.17 | -7.66% | $87.88M | vs PMN |
| INCRIntercure Ltd. | 5.13 | 0.00% | $76.97M | vs PMN |
| RFLRafael Holdings Inc. Class B | 1.48 | +0.01% | $76.97M | vs PMN |
| NTHINeOnc Technologies Holdings Inc. | 2.67 | -1.66% | $76.77M | vs PMN |
Indexes, lists and sector
ProMIS Neurosciences stock FAQ
What is ProMIS Neurosciences's stock price today?
PMN last traded at $9.28 as of Oct 8, 10:14 AM EDT, up 1.72% on the day. Prices are delayed at least 15 minutes.
Does ProMIS Neurosciences pay a dividend?
No. ProMIS Neurosciences does not currently pay a regular cash dividend.
When is ProMIS Neurosciences's next earnings date?
ProMIS Neurosciences is expected to report earnings on Friday, November 13, 2026.
Has PMN ever split its stock?
Yes. The most recent PMN stock split was a 1-for-25 split on Nov 28, 2025, one of 2 splits on record.
What is the PMN 52-week high?
The 52-week high for PMN is $27.40 and the 52-week low is $6.27. The stock is currently 66.1% below its high.